Browsing Over 287 Sessions

Sort By
View
Salamanca Auditorium (Hall 3) Multidisciplinary session

Defining optimal response in myeloma (ID 13)

Date
29.09.2019
Time
10:30 - 11:30
Location
Salamanca Auditorium (Hall 3)
Chairs
  • Jesus F. San-Miguel (Pamplona, Spain)
Pamplona Auditorium (Hall 2) Special symposium

DNA damage response modification as a therapeutic strategy in head and neck cancer (ID 14)

Date
29.09.2019
Time
08:30 - 10:00
Location
Pamplona Auditorium (Hall 2)
Chairs
  • Irene Brana (Barcelona, Spain)
  • Amanda Psyrri (Athens, Greece)
Pamplona Auditorium (Hall 2) Educational session

DNA repair: From basic science to the clinic and back (ID 15)

Date
29.09.2019
Time
10:15 - 11:45
Location
Pamplona Auditorium (Hall 2)
Chairs
  • Ivan Dikic (Frankfurt, Germany)
  • Thomas Helleday (Stockholm, Sweden)
Salamanca Auditorium (Hall 3) Challenge your expert

Drug interaction and the key role of kidney function in onco-haematology (ID 16)

Date
30.09.2019
Time
10:30 - 11:30
Location
Salamanca Auditorium (Hall 3)
Chairs
  • Ben Sprangers (Leuven, Belgium)
Alicante Auditorium (Hall 3) Challenge your expert

Early diagnosis of neuroendocrine tumours (NETs): Increasing awareness and optimising diagnostic work up (ID 17)

Date
29.09.2019
Time
08:45 - 09:45
Location
Alicante Auditorium (Hall 3)
Chairs
  • Kjell Oeberg (Uppsala, Sweden)
Sevilla Auditorium (Hall 2) Educational session

Frontline in mRCC: Ready to select treatment? (ID 18)

Date
27.09.2019
Time
16:00 - 17:30
Location
Sevilla Auditorium (Hall 2)
Chairs
  • Camillo Guglielmo Porta (Pavia, Italy)
  • Manuela Schmidinger (Vienna, Austria)
Sevilla Auditorium (Hall 2) Educational session

Genomic tumour boards to deliver better prostate cancer care (ID 19)

Date
29.09.2019
Time
10:15 - 11:45
Location
Sevilla Auditorium (Hall 2)
Chairs
  • Joaquin Mateo (Barcelona, Spain)
  • Mark A. Rubin (Bern, US, Switzerland)
Malaga Auditorium (Hall 5) Special symposium

Glioblastoma treatment: Where should the future lead? (ID 20)

Date
29.09.2019
Time
10:15 - 11:45
Location
Malaga Auditorium (Hall 5)
Chairs
  • Nicolaus Andratschke (Zurich, Switzerland)
  • Emilie Le Rhun (Lille, CEDEX, France)
Bilbao Auditorium (Hall 5) Challenge your expert

How do we personalise treatment in stage III NSCLC? (ID 21)

Date
30.09.2019
Time
10:30 - 11:30
Location
Bilbao Auditorium (Hall 5)
Chairs
  • Miklos Pless (Winterthur, Switzerland)
Cordoba Auditorium (Hall 7) Challenge your expert

How to choose between single agent and combination immunotherapy (ID 22)

Date
29.09.2019
Time
10:30 - 11:30
Location
Cordoba Auditorium (Hall 7)
Chairs
  • John B. Haanen (Amsterdam, Netherlands)
Sevilla Auditorium (Hall 2) Educational session

How to handle comorbidities in the treatment decision of stages I to III NSCLC (ID 23)

Date
30.09.2019
Time
16:30 - 18:00
Location
Sevilla Auditorium (Hall 2)
Chairs
  • Johan F. Vansteenkiste (Leuven, Belgium)
  • Ad Verhagen (Nijmegen, Netherlands)
Bilbao Auditorium (Hall 5) Challenge your expert

How to sequence treatment in platinum-sensitive relapsed ovarian cancer (ID 24)

Date
28.09.2019
Time
10:30 - 11:30
Location
Bilbao Auditorium (Hall 5)
Chairs
  • Robert L. Coleman (Houston, TX, United States of America)